MPN study with wearables and patient reports
Part of Blood & lymphatic clinical trials.
This study asks people with MPN (a type of blood cancer) to share how they feel and to wear a smartwatch-like device. It aims to learn more about your symptoms and daily life to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a myeloproliferative neoplasm (MPN), a type of blood cancer.
- You live in the United Kingdom.
- You are 18 years old or older.
- You can have conversations in English comfortably.
- You have a smartphone or mobile phone to use in the study.
- You are willing and able to give your permission to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a type of white blood cell (monocyte) affects myeloproliferative neoplasms, a group of blood cancers. It aims to help doctors better understand these diseases and improve treatment.
This study uses wearable technology (like smartwatches) to monitor your health and quality of life while you receive treatment for blood cancers like myeloma or myelodysplastic syndromes. The goal is to help doctors better understand how blood transfusions and other supportive care affect how you feel day-to-day.
This trial tests a digital lifestyle app designed to help people with myeloproliferative neoplasms (MPNs) manage their health and well-being. You would use the app on your phone or computer and share feedback.
This trial tests if a wearable device paired with a smartphone app can help monitor symptoms in cancer survivors. The goal is to improve how we track and manage symptoms during and after treatment.
This trial tests whether wearing a smartwatch can help monitor your symptoms and get you help faster if you have cancer that has spread to the lining of your brain and spinal cord. You'll wear the watch and use a phone app to track how you're feeling.
This observational registry tracks symptoms, treatments, and disease changes over time in people diagnosed with myeloproliferative neoplasms (MPNs). By joining, you help doctors learn more about the condition and possibly contribute to better future care.
Hear when a new Myeloproliferative Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.